Skip to content

Study · In vitro (cells) · mouse · 2020

7 results

Mitogen- and stress-activated protein kinase-1 activation is involved in melanocortin-induced BDNF expression in Neuro2a neuronal cells.

Zhang W, Wu Y

Neuroreport1 Oct 2020Cited by 7 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study7

7 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Efficacy outcome

    In Neuro2a murine neuronal cells, NDP-MSH promoted neurite outgrowth.

    In plain wordsIn lab-grown mouse nerve cells, NDP-MSH promoted the growth of nerve cell extensions.

    Outcome
    IncreaseNeurite outgrowth
    Study

    Mousen: not reported in source

    Neuro2a murine neuronal cells
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In Neuro2a cells, NDP-MSH promoted neurite outgrowth.
  2. 02LabIn vitro (cells)Mechanism

    In Neuro2a murine neuronal cells, NDP-MSH greatly enhanced BDNF expression.

    In plain wordsIn lab-grown mouse nerve cells, NDP-MSH greatly raised the expression of BDNF.

    Outcome
    IncreaseBDNF expression
    Study

    Mousen: not reported in source

    Neuro2a murine neuronal cells
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Upon NDP-MSH administration, BDNF expression was greatly enhanced.
  3. 03LabIn vitro (cells)Mechanism

    In Neuro2a murine neuronal cells, the MC4R antagonist JKC-363 reversed the NDP-MSH-induced BDNF increase.

    In plain wordsIn lab-grown mouse nerve cells, a blocker of the MC4R receptor reversed the BDNF rise caused by NDP-MSH.

    Outcome
    Not applicableBDNF expression with MC4R antagonist JKC-363
    Study

    Mousen: not reported in source

    Neuro2a murine neuronal cells
    Outcome group
    Receptor activity and mechanism · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Furthermore, this effect was effectively reversed by the MC4R antagonist, JKC-363.
  4. 04LabIn vitro (cells)Mechanism

    In Neuro2a murine neuronal cells, NDP-MSH treatment activated the ERK cascade.

    In plain wordsIn lab-grown mouse nerve cells, NDP-MSH switched on the ERK signaling cascade.

    Outcome
    IncreaseERK cascade activation
    Study

    Mousen: not reported in source

    Neuro2a murine neuronal cells
    Outcome group
    Receptor activity and mechanism · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    We found that NDP-MSH treatment activated the ERK cascade
  5. 05LabIn vitro (cells)Mechanism

    In Neuro2a murine neuronal cells, NDP-MSH treatment activated the downstream kinase MSK1.

    In plain wordsIn lab-grown mouse nerve cells, NDP-MSH switched on the signaling enzyme MSK1.

    Outcome
    IncreaseMSK1 activation
    Study

    Mousen: not reported in source

    Neuro2a murine neuronal cells
    Outcome group
    Receptor activity and mechanism · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    We found that NDP-MSH treatment activated the ERK cascade and its downstream kinase MSK1 (mitogen- and stress-activated protein kinase-1).
  6. 06LabIn vitro (cells)Mechanism

    In Neuro2a murine neuronal cells, MSK1 inhibition or a defective MSK1 mutant interrupted CREB phosphorylation and blocked BDNF upregulation.

    In plain wordsIn lab-grown mouse nerve cells, blocking MSK1 stopped CREB activation and the BDNF rise seen with NDP-MSH.

    Outcome
    Not applicableCREB phosphorylation and BDNF upregulation with MSK1 inhibition
    Study

    Mousen: not reported in source

    Neuro2a murine neuronal cells
    Outcome group
    Receptor activity and mechanism · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Antagonism of the MSK1 cascade by a specific inhibitor or overexpression of a defective MSK1 mutant interrupted the phosphorylation of the transcription factor cAMP-response element binding protein (CREB), blocking BDNF upregulation.
  7. 07LabIn vitro (cells)Mechanism

    In Neuro2a murine neuronal cells, MSK1 activation triggered an epigenetic alteration in histone H3 (Ser10) that facilitated BDNF gene expression.

    In plain wordsIn lab-grown mouse nerve cells, MSK1 activation changed histone H3, which helped switch on the BDNF gene.

    Outcome
    Not applicableHistone H3 (Ser10) alteration by MSK1 activation
    Study

    Mousen: not reported in source

    Neuro2a murine neuronal cells
    Outcome group
    Receptor activity and mechanism · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In addition, MSK1 activation triggered an epigenetic alteration in histone H3 (Ser10), facilitating the expression of the BDNF gene.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.